cefuroxime 250 MG Oral Tablet
cefuroxime
RxCUI: 309097
What the CMS Formulary Data Shows for cefuroxime 250 MG Oral Tablet
Per the CMS 2026 Part D formulary file, cefuroxime 250 MG Oral Tablet (RxNorm concept RXCUI 309097, generic name cefuroxime) appears on 330 distinct formulary files spanning 5,067 Medicare Part D plan offerings - 100% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 1.9.
Real-world access to cefuroxime 250 MG Oral Tablet depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 873,273 Part D beneficiaries filled cefuroxime 250 MG Oral Tablet in 2023, with total plan-and-beneficiary spending of $20,650,959 and an average per-beneficiary annual cost of $23.65. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry cefuroxime 250 MG Oral Tablet today.
Coverage Details
- Formularies covering
- 330
- Plans covering
- 5,067
- Coverage rate
- 100%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 2, Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 873,273
- Total spending
- $20,650,959
- Avg per beneficiary
- $23.65
Tier Distribution Across Plans
Standalone Drug Plans (PDP) Covering cefuroxime 250 MG Oral Tablet
5 standalone prescription drug plans include this drug.
| Plan | Insurer | Tier | PA | ST | Premium | States |
|---|---|---|---|---|---|---|
| Anthem Full Dual Advantage (PPO D-SNP) | ANTHEM HEALTH PLANS, INC. | T1 | No | No | $0 | CT |
| Anthem Dual Advantage (PPO D-SNP) | ANTHEM HEALTH PLANS, INC. | T1 | No | No | $0 | CT |
| Anthem Kidney Care (HMO-POS C-SNP) | ANTHEM HEALTH PLANS, INC. | T1 | No | No | $0 | CT |
| Anthem Full Dual Advantage Select (HMO D-SNP) | ANTHEM HEALTH PLANS, INC. | T1 | No | No | $0 | CT |
| Anthem Dual Advantage (HMO D-SNP) | ANTHEM HEALTH PLANS, INC. | T1 | No | No | $0 | CT |
Medicare Advantage Plans (MA-PD) Covering cefuroxime 250 MG Oral Tablet
95 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is cefuroxime 250 MG Oral Tablet covered by Medicare Part D?
Yes, cefuroxime 250 MG Oral Tablet is covered by 5,067 Medicare Part D plans (100% of all Part D formularies).
What tier is cefuroxime 250 MG Oral Tablet on Medicare Part D plans?
cefuroxime 250 MG Oral Tablet averages Tier 1.9 across Part D plans, ranging from Tier 1 to Tier 4.
Does cefuroxime 250 MG Oral Tablet require prior authorization?
0% of Part D formularies require prior authorization for cefuroxime 250 MG Oral Tablet. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on cefuroxime 250 MG Oral Tablet?
In 2023, total Medicare Part D spending on cefuroxime 250 MG Oral Tablet was $20,650,959, covering 873,273 beneficiaries. The average spend per beneficiary was $23.65.
Read our methodology - how this data is sourced, computed, and verified.